Sept 8 (Reuters) - (This Sept. 8 story has been corrected to add the missing words 'from the risks' to the FDA statement, in paragraph 7) The U.S. Food and Drug Administration plans to fast-track ...

The FDA will put three psychedelic drug programs on an ultra-fast approval track, compressing review timelines from roughly 10 to 12 months to as little as one to two months. The agency announced in ...

The Food and Drug Administration announced on Thursday the first round of experimental drugs to be included in a priority voucher program. This FDA initiative is designed to expedite drug review ...

Oct 3 (Reuters) - The U.S. Food and Drug Administration said on Friday it has launched a new pilot program to speed up the review process for generic drugs that are tested and manufactured entirely in ...

(Reuters) - The U.S. Food and Drug Administration plans to fast-track reviews of four tobacco firms' nicotine pouches in a pilot program launching on Monday, amid pressure from the Trump ...

(Reuters) -The U.S. Food and Drug Administration plans to fast-track reviews of four tobacco firms' nicotine pouches in a pilot program launching on Monday, amid pressure from the Trump administration ...